In resistant hypertension, amiloride was noninferior to spironolactone for reducing home SBP at 12 wk
Year: 2025
Type: article
Source: Annals of Internal Medicine
Authors: Giulio Francesco Romiti, Niccolò Bonini
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4413888476
